Tailwind Capital sale of ArrowStream
We advised Tailwind Capital on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Taibang Biologic Group $300 million equity raising
We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
General Motors $2.25 billion inaugural green bond offering
The investment-grade notes offering consists of two tranches
Transocean amendment and extension of revolving credit facility
We advised the administrative agent, joint lead arranger and lender on the facility
Ygrene Energy Series C funding
We advised Lightyear Capital on the transaction
Bank of America $10 billion fixed-to-floating-rate notes
The investment-grade debt offering is based on the Secured Overnight Financing Rate
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Legend Biotech $403 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
CSX $2 billion senior notes offering
We advised CSX on the investment-grade debt offering
Envision Healthcare and AMSURG $600 million new credit facilities
We advised the agent on an amendment including a $300 million “first out” tranche and on a new $300 million revolver